(GNE) Genie Energy - Overview
Stock: Electricity, Natural Gas, Solar Panels, Advisory
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.87% |
| Yield on Cost 5y | 4.13% |
| Yield CAGR 5y | -7.98% |
| Payout Consistency | 73.0% |
| Payout Ratio | 148.4% |
| Risk 5d forecast | |
|---|---|
| Volatility | 30.8% |
| Relative Tail Risk | -1.07% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.09 |
| Alpha | -11.74 |
| Character TTM | |
|---|---|
| Beta | 0.475 |
| Beta Downside | 0.276 |
| Drawdowns 3y | |
|---|---|
| Max DD | 53.68% |
| CAGR/Max DD | 0.09 |
Description: GNE Genie Energy December 25, 2025
Genie Energy Ltd. (NYSE:GNE) operates two core businesses: Genie Retail Energy, which markets electricity and natural gas to residential and small-business customers across the Eastern, Midwestern U.S., and Texas, and Genie Renewables, which builds, owns, and operates utility-scale solar farms while also distributing solar panels and providing procurement advisory services to larger commercial and municipal clients.
As of Q4 2023, Genie reported total revenue of $215 million, with the retail segment contributing roughly 62 % and the renewables segment 38 %. The company’s solar pipeline now exceeds 350 MW of projects slated for construction through 2026, positioning it to benefit from the Inflation Reduction Act’s investment tax credit, which currently stands at 30 % for qualified solar assets.
Key economic drivers for Genie include the volatility of natural-gas wholesale prices, which directly affect retail margins, and the accelerating demand for clean-energy procurement among corporate and municipal customers-a trend reflected in a 15 % YoY increase in its advisory contracts. The firm’s exposure to regulated utility-scale solar also provides a hedge against retail price pressure.
For a deeper, data-rich view of how these dynamics translate into valuation metrics, you might explore the analyst tools on ValueRay to see GNE’s forward-looking cash-flow scenarios.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 4.85m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA -7.13 > 1.0 |
| NWC/Revenue: 23.43% < 20% (prev 32.50%; Δ -9.06% < -1%) |
| CFO/TA 0.11 > 3% & CFO 43.4m > Net Income 4.85m |
| Net Debt (-100.4m) to EBITDA (10.6m): -9.44 < 3 |
| Current Ratio: 1.91 > 1.5 & < 3 |
| Outstanding Shares: last quarter (26.4m) vs 12m ago -1.78% < -2% |
| Gross Margin: 25.72% > 18% (prev 0.32%; Δ 2540 % > 0.5%) |
| Asset Turnover: 131.4% > 50% (prev 125.0%; Δ 6.33% > 0%) |
| Interest Coverage Ratio: 7.62 > 6 (EBITDA TTM 10.6m / Interest Expense TTM 1.27m) |
Altman Z'' 3.14
| A: 0.29 (Total Current Assets 238.2m - Total Current Liabilities 124.9m) / Total Assets 394.1m |
| B: 0.20 (Retained Earnings 78.7m / Total Assets 394.1m) |
| C: 0.03 (EBIT TTM 9.68m / Avg Total Assets 367.9m) |
| D: 0.41 (Book Value of Equity 83.8m / Total Liabilities 205.3m) |
| Altman-Z'' Score: 3.14 = A |
Beneish M -2.64
| DSRI: 1.04 (Receivables 59.0m/50.3m, Revenue 483.3m/427.2m) |
| GMI: 1.26 (GM 25.72% / 32.46%) |
| AQI: 1.21 (AQ_t 0.32 / AQ_t-1 0.26) |
| SGI: 1.13 (Revenue 483.3m / 427.2m) |
| TATA: -0.10 (NI 4.85m - CFO 43.4m) / TA 394.1m) |
| Beneish M-Score: -2.64 (Cap -4..+1) = A |
What is the price of GNE shares?
Over the past week, the price has changed by +2.76%, over one month by +1.36%, over three months by -3.05% and over the past year by -0.12%.
Is GNE a buy, sell or hold?
- StrongBuy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the GNE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 16 | 13.1% |
| Analysts Target Price | 16 | 13.1% |
| ValueRay Target Price | 14.4 | 2% |
GNE Fundamental Data Overview February 03, 2026
P/S = 0.761
P/B = 1.8418
Revenue TTM = 483.3m USD
EBIT TTM = 9.68m USD
EBITDA TTM = 10.6m USD
Long Term Debt = 6.71m USD (from longTermDebt, last quarter)
Short Term Debt = 2.13m USD (from shortTermDebt, last quarter)
Debt = 8.85m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -100.4m USD (from netDebt column, last quarter)
Enterprise Value = 288.5m USD (388.9m + Debt 8.85m - CCE 109.3m)
Interest Coverage Ratio = 7.62 (Ebit TTM 9.68m / Interest Expense TTM 1.27m)
EV/FCF = 8.25x (Enterprise Value 288.5m / FCF TTM 35.0m)
FCF Yield = 12.12% (FCF TTM 35.0m / Enterprise Value 288.5m)
FCF Margin = 7.23% (FCF TTM 35.0m / Revenue TTM 483.3m)
Net Margin = 1.00% (Net Income TTM 4.85m / Revenue TTM 483.3m)
Gross Margin = 25.72% ((Revenue TTM 483.3m - Cost of Revenue TTM 359.0m) / Revenue TTM)
Gross Margin QoQ = 21.70% (prev 22.31%)
Tobins Q-Ratio = 0.73 (Enterprise Value 288.5m / Total Assets 394.1m)
Interest Expense / Debt = 9.57% (Interest Expense 847.0k / Debt 8.85m)
Taxrate = 26.83% (2.47m / 9.20m)
NOPAT = 7.09m (EBIT 9.68m * (1 - 26.83%))
Current Ratio = 1.91 (Total Current Assets 238.2m / Total Current Liabilities 124.9m)
Debt / Equity = 0.04 (Debt 8.85m / totalStockholderEquity, last quarter 198.8m)
Debt / EBITDA = -9.44 (Net Debt -100.4m / EBITDA 10.6m)
Debt / FCF = -2.87 (Net Debt -100.4m / FCF TTM 35.0m)
Total Stockholder Equity = 196.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.32% (Net Income 4.85m / Total Assets 394.1m)
RoE = 2.47% (Net Income TTM 4.85m / Total Stockholder Equity 196.1m)
RoCE = 4.77% (EBIT 9.68m / Capital Employed (Equity 196.1m + L.T.Debt 6.71m))
RoIC = 3.46% (NOPAT 7.09m / Invested Capital 205.1m)
WACC = 7.66% (E(388.9m)/V(397.8m) * Re(7.67%) + D(8.85m)/V(397.8m) * Rd(9.57%) * (1-Tc(0.27)))
Discount Rate = 7.67% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -0.61%
[DCF Debug] Terminal Value 74.88% ; FCFF base≈42.8m ; Y1≈32.6m ; Y5≈20.0m
Fair Price DCF = 20.07 (EV 399.7m - Net Debt -100.4m = Equity 500.1m / Shares 24.9m; r=7.66% [WACC]; 5y FCF grow -28.35% → 2.90% )
EPS Correlation: -53.36 | EPS CAGR: -13.35% | SUE: 1.04 | # QB: 1
Revenue Correlation: 62.77 | Revenue CAGR: 73.51% | SUE: 0.03 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.19 | Chg30d=-0.230 | Revisions Net=+0 | Analysts=1
EPS next Year (2026-12-31): EPS=0.56 | Chg30d=-0.210 | Revisions Net=+0 | Growth EPS=-33.3% | Growth Revenue=+7.1%